Nvidia-backed Iambic Therapeutics jumps in debut after $150 million IPO
15/10/2026 19:31
BUZZ-Nvidia-backed Iambic Therapeutics jumps in debut after $150 million IPO ** Iambic Therapeutics IAM.O shares jump 19% to $19.08 in Nasdaq debut after $150 million US IPO
** Nvidia-backed drug developer's stock opened at $16.15 apiece vs $16 IPO price
** San Diego, California-based IAM sold 9.38 mln shares within $15 to $17 apiece marketed range
** Biotech remains a bright spot in choppy broader IPO market
** "For now, this looks more like a speed bump than a three-car pileup.. we've seen pullbacks like this before" - Matt Kennedy, senior strategist at Renaissance Capital
** Iambic is advancing a pipeline of drug candidates developed using its AI platform to treat solid tumors
(Reporting by Arasu Kannagi Basil in Bengaluru)
Recent news on NVIDIA
See all newsBrief: Rockwell Automation Expands Factorytalk Conductor With Nvidia Nemotron Support
U.S. STOCKS ON THE MOVE-Quest Diagnostics, Tractor Supply, Dutch Bros
Analysis: Anthropic IPO stands alone as AI market jitters sideline others
US chip stocks fall after fleeting respite in previous session
Factbox: Pharma sector doubles down on AI to slash costs, timelines